<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2016-04-29</publicationDate>
    
        <volume>5</volume>
        <issue>2</issue>

 
    <startPage>863</startPage>
    <endPage>866</endPage>

	    <publisherRecordId>8684</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Determination of mirtazapine in tablet dosage forms by visible spectrophotometry</title>

    <authors>
	 


      <author>
       <name>D. Ravi Kumar</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name> V. Naga Lakshmi1</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>S.V.M.Vardhan</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>C. Rambabu</name>

		
	<affiliationId>3</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Two visible spectrophotometric methods have been developed for the quantitative estimation of Mirtazapine from its tablet formulations. The first method (method-A) is based on internal salt formation of red to violet colored chromogen of drug with citric acid – acetic anhydride which shows lmax at 580nm and linearity was observed in the concentration range of 8-40 μg.mL-1. The percentage recovery of drug from tablet formulation using this method was found to be in the range of 99.50-99.83 %. The second developed method (method-B) based on redox reaction of drug with Fe (III) – hexacyano ferrate (III) which shows lmax at 740 nm and linearity was observed in the concentration range of 5-25 μg.mL-1. The percentage recovery of drug from tablet formulation using this method was found to be in the range of 99.15-99.91 % Analysis of results for both developed methods were validated statistically. Recovery study results were close to 100%. The developed methods were found to be simple, rapid, accurate and repro9ducible. Both the methods are suitable for the estimation of mirtazapine from tablet dosage forms.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol5no2/determination-of-mirtazapine-in-tablet-dosage-forms-by-visible-spectrophotometry/</fullTextUrl>



      <keywords language="eng">
        <keyword>Mirtazapine;hexacyanoferrate(III)</keyword>
      </keywords>

  </record>
</records>